Fabio Francavilla

5PUBLICATIONS
28CO-AUTHORS
Medical infection agents (incl. prions)Autonomic nervous systemBiologically active moleculesReaction kinetics and dynamics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 15, 2026
Toward a Therapy for Autism Spectrum Disorder: The Formyl Peptide Receptor 2 Agonist MR-39 Supports Synaptic Health in the BTBR Mouse and Features a Favorable Safety Profile.

|Jan 28, 2026
Beyond Radical Scavengers: Focus on NADPH Oxidases (NOX) Inhibitors as New Agents for Antioxidant Therapy in Alzheimer's Disease.

Leonardo Brunetti, Fabio Francavilla, Angela Santo

|Aug 23, 2025
Design, Synthesis, and Biological Evaluation of Novel Heteroaryl, Squaramide, and Indolcarboxamide Derivatives as Formyl Peptide Receptor 2 Agonists to Target Neuroinflammation.

Fabio Francavilla, Daniele Vitone, Igor A Schepetkin

|Aug 12, 2025
Conformational Restriction of Designer Drugs Reveals Subtype-Selective and Biased CB2 Agonists with Neuroprotective Effects.

Claudia Gioé-Gallo, Sandra Ortigueira, Rubén Prieto-Díaz

|Jul 29, 2025
Hydrogen Sulfide (H2S)-Donating Formyl Peptide Receptor 2 (FPR2) Agonists: Design, Synthesis, and Biological Evaluation in Primary Mouse Microglia Culture.

Leonardo Brunetti, Fabio Francavilla, Mauro Niso

Pageof 1

Frequent Collaborators

4 joint publications

Enza Lacivita

4 joint publications

Marcello Leopoldo

3 joint publications

Leonardo Brunetti

2 joint publications

Mark T Quinn